Search Result "apixaban."
Apixaban: A New Player in the Anticoagulant Class
Journal: Current Drug Targets
Volume: 13 Issue: 6 Year: 2012 Page: 863-875
Author(s): Ritesh Agrawal,Pratima Jain,S. N. Dikshit
Apixaban - Metabolism, Pharmacologic Properties and Drug Interactions
Journal: Current Drug Metabolism
Volume: 18 Issue: 7 Year: 2017 Page: 609-621
Author(s): Peter Kubisz,Lucia Stanciakova,Miroslava Dobrotova,Matej Samos,Marian Mokan,Jan Stasko
To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban
Journal: Current Drug Targets
Volume: 19 Issue: 6 Year: 2018 Page: 581-584
Author(s): Marco Matteo Ciccone,Annapaola Zito,Fiorella Devito,Maria Maiello,Pasquale Palmiero
Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
Journal: Current Cardiology Reviews
Volume: 13 Issue: 1 Year: 2017 Page: 41-46
Author(s): Kenechukwu Mezue,Chukwudi Obiagwu,Jinu John,Abhishek Sharma,Felix Yang,Jacob Shani
New Advances in Atrial Fibrillation Management: The Role of Apixaban
Journal: Current Drug Targets
Volume: 19 Issue: 6 Year: 2018 Page: 585-592
Author(s): Giuseppe M.C. Rosano,Ilaria Spoletini,Walter Gianni,Cristiana Vitale
Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 15 Issue: 2 Year: 2015 Page: 139-147
Author(s): Mohit K. Turagam,Poonam Velagapudi,Oluwaseun Adeola,Bhavana Chinnakotla,Martin A. Alpert
Deep Vein Thrombosis and Pulmonary Embolism in the Apixaban Era: From Bench to Bedside
Journal: Current Drug Targets
Volume: 19 Issue: 6 Year: 2018 Page: 577-580
Author(s): Pavel Poredos,Mateja Kaja Jezovnik
Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 34 Year: 2017 Page: 3813-3827
Author(s): Francesca Cortese,Pietro Scicchitano,Michele Gesualdo,Gabriella Ricci,Santa Carbonara,Carlo Franchini,Brigida Immacolata Pia Schiavone,Filomena Corbo,Marco Matteo Ciccone
Oral Factor Xa (FXa) Inhibitors for Treatment of Heparin-induced Thrombocytopenia (HIT)
Journal: Current Drug Therapy
Volume: 16 Issue: 2 Year: 2021 Page: 126-132
Author(s): Nicholas Munafo,Sagar Patel,Kristine C. Willett,Amanda Morrill
Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?
Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 2 Year: 2011 Page: 147-157
Author(s): Sheila Anne Doggrell